• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺大细胞神经内分泌癌:14例病例系列

Large Cell Neuroendocrine Carcinoma of the Lung: A Case Series of 14 Cases.

作者信息

Hayoune Amine, Mahfoud Imane, Thouil Afaf, Kouismi Hatim

机构信息

Department of Respiratory Diseases, Faculty of Medicine and Pharmacy of Oujda, Mohammed VI University Hospital, Mohamed First University, Oujda, MAR.

Department of Respiratory Diseases, Research and Medical Sciences Laboratory, Faculty of Medicine and Pharmacy of Oujda, Mohammed VI University Hospital, Mohamed First University, Oujda, MAR.

出版信息

Cureus. 2022 Aug 1;14(8):e27559. doi: 10.7759/cureus.27559. eCollection 2022 Aug.

DOI:10.7759/cureus.27559
PMID:36059356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9428409/
Abstract

Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rare subtype of neuroendocrine tumor, presenting with very aggressive behavior and a poor prognosis. The diagnosis is difficult and requires histological confirmation of the neuroendocrine nature by an immunohistochemical study on a biopsy sample. We retrospectively studied a series of 14 patients from the pneumology department of the Mohammed VI University Hospital of Oujda, Morocco, over a period of five years (from April 2017 to March 2021). The average age was 63.41 years (45-80 years). All our patients were male and smokers. The clinical signs were dominated by deterioration in general condition and dyspnea. Bronchoscopy was performed in 92% of patients, with neoplastic stenosis being the main found aspect, in 35% of cases. The histological diagnosis was obtained by bronchoscopy in 50% of cases. In the remaining cases, it was carried by CT-guided transparietal biopsy in 28% of cases, pleural biopsy in 7% of cases, biopsy of a metastatic site in 7% of cases and finally thoracoscopy with pleural biopsy in the remaining 7% of cases. Therapeutically, no patient received surgical treatment and three patients were put on palliative treatment. The positive diagnosis is often late, which makes the prognosis bad and the therapeutic possibilities limited. Hence the importance of strategies for the prevention of tobacco control and early detection in population at risk.

摘要

肺大细胞神经内分泌癌(LCNEC)是神经内分泌肿瘤的一种罕见亚型,具有非常侵袭性的行为和较差的预后。诊断困难,需要通过对活检样本进行免疫组织化学研究来证实神经内分泌性质。我们回顾性研究了摩洛哥乌季达穆罕默德六世大学医院肺病科在五年期间(2017年4月至2021年3月)的14例患者。平均年龄为63.41岁(45 - 80岁)。我们所有的患者均为男性且吸烟。临床症状以全身状况恶化和呼吸困难为主。92%的患者进行了支气管镜检查,其中35%的病例主要发现为肿瘤性狭窄。50%的病例通过支气管镜检查获得组织学诊断。在其余病例中,28%通过CT引导下经壁活检、7%通过胸膜活检、7%通过转移部位活检,最后7%通过胸腔镜联合胸膜活检获得诊断。在治疗方面,没有患者接受手术治疗,3例患者接受了姑息治疗。阳性诊断往往较晚,这使得预后不良且治疗可能性有限。因此,在高危人群中开展烟草控制预防和早期检测策略非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f153/9428409/d13f9811ad6b/cureus-0014-00000027559-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f153/9428409/fac8674b82df/cureus-0014-00000027559-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f153/9428409/da6cd3085f17/cureus-0014-00000027559-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f153/9428409/9f988fd0112d/cureus-0014-00000027559-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f153/9428409/aa4416e7a743/cureus-0014-00000027559-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f153/9428409/d13f9811ad6b/cureus-0014-00000027559-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f153/9428409/fac8674b82df/cureus-0014-00000027559-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f153/9428409/da6cd3085f17/cureus-0014-00000027559-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f153/9428409/9f988fd0112d/cureus-0014-00000027559-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f153/9428409/aa4416e7a743/cureus-0014-00000027559-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f153/9428409/d13f9811ad6b/cureus-0014-00000027559-i05.jpg

相似文献

1
Large Cell Neuroendocrine Carcinoma of the Lung: A Case Series of 14 Cases.肺大细胞神经内分泌癌:14例病例系列
Cureus. 2022 Aug 1;14(8):e27559. doi: 10.7759/cureus.27559. eCollection 2022 Aug.
2
Pathological diagnosis of pulmonary large cell neuroendocrine carcinoma by endobronchial ultrasound-guided transbronchial needle aspiration.经支气管超声引导经支气管针吸术对肺大细胞神经内分泌癌的病理诊断。
Thorac Cancer. 2018 Feb;9(2):273-277. doi: 10.1111/1759-7714.12576. Epub 2017 Dec 22.
3
Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.肺神经内分泌肿瘤 90 例临床病理特征、免疫表型、术前活检及冷冻切片诊断研究
J Surg Oncol. 2014 Mar;109(3):280-6. doi: 10.1002/jso.23497. Epub 2013 Dec 3.
4
Value of cytology in small cell lung carcinoma diagnostic--single-center study.细胞学检查在小细胞肺癌诊断中的价值——单中心研究
Coll Antropol. 2014 Jun;38(2):611-6.
5
Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.胆囊神经内分泌癌:19例病例系列及文献复习
J Gastrointest Cancer. 2015 Dec;46(4):356-64. doi: 10.1007/s12029-015-9745-9.
6
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy.肺大细胞神经内分泌癌:从流行病学到治疗
J Thorac Oncol. 2015 Aug;10(8):1133-41. doi: 10.1097/JTO.0000000000000589.
7
Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?免疫组织化学染色阳性神经内分泌标记物的总和对活检标本中大细胞神经内分泌癌(LCNEC)的诊断是否有用?
Histopathology. 2019 Mar;74(4):555-566. doi: 10.1111/his.13800. Epub 2019 Jan 24.
8
Treatment of lung large cell neuroendocrine carcinoma.肺大细胞神经内分泌癌的治疗。
Tumour Biol. 2016 Jun;37(6):7047-57. doi: 10.1007/s13277-016-5003-4. Epub 2016 Mar 4.
9
Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.纯型和混合型肺大细胞神经内分泌癌患者临床结局的差异:一项多中心回顾性研究。
Lung Cancer. 2020 Jan;139:118-123. doi: 10.1016/j.lungcan.2019.11.004. Epub 2019 Nov 11.
10
Large cell neuroendocrine carcinoma of the larynx: definition of an entity.喉大细胞神经内分泌癌:一种实体的定义
Head Neck Pathol. 2010 Sep;4(3):198-207. doi: 10.1007/s12105-010-0188-0. Epub 2010 Jun 30.

本文引用的文献

1
Pathological diagnosis of pulmonary large cell neuroendocrine carcinoma by endobronchial ultrasound-guided transbronchial needle aspiration.经支气管超声引导经支气管针吸术对肺大细胞神经内分泌癌的病理诊断。
Thorac Cancer. 2018 Feb;9(2):273-277. doi: 10.1111/1759-7714.12576. Epub 2017 Dec 22.
2
Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.肺大细胞神经内分泌癌:临床病理特征、治疗及预后
Clin Lung Cancer. 2016 Sep;17(5):e121-e129. doi: 10.1016/j.cllc.2016.01.003. Epub 2016 Jan 21.
3
Clinical features of large cell neuroendocrine carcinoma: a population-based overview.
大细胞神经内分泌癌的临床特征:一项基于人群的概述。
Eur Respir J. 2016 Feb;47(2):615-24. doi: 10.1183/13993003.00618-2015. Epub 2015 Nov 5.
4
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy.肺大细胞神经内分泌癌:从流行病学到治疗
J Thorac Oncol. 2015 Aug;10(8):1133-41. doi: 10.1097/JTO.0000000000000589.
5
Diagnosis and treatment of neuroendocrine lung tumors.神经内分泌性肺肿瘤的诊断与治疗
Arch Bronconeumol. 2014 Sep;50(9):392-6. doi: 10.1016/j.arbres.2014.02.004. Epub 2014 Mar 28.
6
Clinicopathological features and the impact of the new TNM classification of malignant tumors in patients with pulmonary large cell neuroendocrine carcinoma.肺大细胞神经内分泌癌患者的临床病理特征及恶性肿瘤新TNM分类的影响
Mol Clin Oncol. 2013 May;1(3):437-443. doi: 10.3892/mco.2013.80. Epub 2013 Feb 28.
7
Gastric carcinoids (neuroendocrine neoplasms).胃类癌(神经内分泌肿瘤)。
Gastroenterol Clin North Am. 2013 Jun;42(2):381-97. doi: 10.1016/j.gtc.2013.01.009. Epub 2013 Mar 1.
8
Surgical management of pulmonary large cell neuroendocrine carcinomas: a 10-year experience.肺大细胞神经内分泌癌的外科治疗:10 年经验。
Eur J Cardiothorac Surg. 2013 Jan;43(1):111-4. doi: 10.1093/ejcts/ezs174. Epub 2012 Apr 23.
9
Advances in neuroendocrine lung tumors.神经内分泌肺肿瘤的研究进展。
Ann Oncol. 2010 Oct;21 Suppl 7:vii65-71. doi: 10.1093/annonc/mdq380.
10
Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.肺大细胞神经内分泌癌的围手术期辅助化疗的临床反应。
Anticancer Drugs. 2010 Jan;21(1):89-93. doi: 10.1097/CAD.0b013e328330fd79.